Clinical trial
Glutamine Supplementation to Prevent Death or Infection in Extremely Premature…
NCT00005775 · NICHD Neonatal Research Network, Other · Completed
Key facts
| NCT number | NCT00005775 |
|---|---|
| Title | Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants |
| Official title | Randomized Controlled Trial of Parenteral Glutamine Supplementation for Extremely-Low-Birth-Weight (ELBW) Infants |
| Acronym | Glutamine |
| Lead sponsor | NICHD Neonatal Research Network, Other |
| Collaborators | National Center for Research Resources (NCRR) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infant, Newborn, Low Birth Weight, Small for Gestational Age, Premature, Sepsis |
| Intervention type | Drug |
| Interventions | Glutamine, Placebo |
| Enrollment | 1,433 |
| Start date | Jul 1, 1999 |
| Primary completion | Dec 1, 2000 |
| Completion | Aug 1, 2001 |
| First posted | Jun 2, 2000 |
| Last update posted | Jun 8, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: